Investing, US News

AstraZeneca’s Antibody Cocktail Only 33 Percent Effective at Preventing Covid Symptoms

NASDAQ:AZN NMA COVID vaccine distribution vaccine trial results testing sites Scalia osha Health companies Julie Gerberding coronavirus wuhan lab accident

Following the mixed success of its vaccine, AstraZeneca Plc (NASDAQ:AZN) faces another blow as its long-acting antibody cocktail AZD7442 failed to prevent symptoms in 33% of people exposed to the SARS-CoV-2 virus in a preliminary study. Q1 2021 hedge fund letters, conferences and more More than 1,100 adults volunteered for the trial in both the […]

The post AstraZeneca’s Antibody Cocktail Only 33 Percent Effective at Preventing Covid Symptoms appeared first on ValueWalk.

Jump To The Original Source

Facebook Comments

Check Also

Microsoft’s first devices with Windows 11 are built for remote work

Published by DPA Microsoft has introduced two new ...

Archives